News

Mundi pharma inks partnership with Samsung Bioepis to expand biosimilars into Hong Kong and Taiwan

Through the partnership, Mundipharma will be the exclusive commercialization partner, while Samsung Bioepis will remain the Marketing Authorisation Holder (MAH)

Read More

Jan 20, 2020

By : Team ABLE

Kiran Mazumdar-Shaw conferred with Australia’s highest civilian honour

An alumnus of Federation University Australia, Mazumdar-Shaw contributes immensely to promoting women in STEM through the joint research programmes developed between Biocon and Deakin University, Australia

Read More

Jan 20, 2020

By : Team ABLE

Metropolis Healthcare buys Ahmedabad’s Shraddha Diagnostics

Pan-India pathology specialist chain Metropolis Healthcare Ltd. has signed a binding agreement to acquire Ahmedabad-based Shraddha Diagnostics Pvt Ltd.

Read More

Jan 20, 2020

By : Team ABLE

WHO Global TB Programincludes Indian Molecular assay TrueNat as initial test for TB and MDR-TB

The TrueNat TB test is a new molecular test that diagnosis TB as well as testing for resistance to the drug rifampicin in about 90 minutes.

Read More

Jan 17, 2020

By : Team ABLE

DGCI approves two new antibiotics developed by Wockhardt

This approval by the Indian drug regulator DCGIis claimed to be the country's first new discovery antibiotics.

Read More

Jan 17, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights